|
Volumn 52, Issue 4, 2013, Pages 478-485
|
Comparison of clinical and cost-effectiveness of psoralen+ultraviolet A versus psoralen+sunlight in the treatment of chronic plaque psoriasis in a developing economy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METHOXSALEN;
ADOLESCENT;
ARTICLE;
BODY SURFACE;
CHILD;
CLINICAL EFFECTIVENESS;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
ECONOMIC EVALUATION;
ERYTHRODERMA;
FEMALE;
FOLLOW UP;
HEALTH CARE COST;
HUMAN;
HYPERPIGMENTATION;
HYPOPIGMENTATION;
INDIA;
INTERMETHOD COMPARISON;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
MORNING DOSAGE;
NAUSEA;
OUTCOME ASSESSMENT;
PHOTO ONYCHOLYSIS;
PHOTOTOXICITY;
PROSPECTIVE STUDY;
PSORIASIS VULGARIS;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
SCHOOL CHILD;
SINGLE DRUG DOSE;
SUN EXPOSURE;
SUNLIGHT;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT RESPONSE;
ULTRAVIOLET A RADIATION;
ADOLESCENT;
ADULT;
AGED;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
DEVELOPING COUNTRIES;
FEMALE;
FICUSIN;
HOSPITAL COSTS;
HUMANS;
INDIA;
MALE;
MIDDLE AGED;
PHOTOSENSITIZING AGENTS;
PSORIASIS;
PUVA THERAPY;
SALARIES AND FRINGE BENEFITS;
SEVERITY OF ILLNESS INDEX;
SUNLIGHT;
TRANSPORTATION;
YOUNG ADULT;
|
EID: 84875073605
PISSN: 00119059
EISSN: 13654632
Source Type: Journal
DOI: 10.1111/j.1365-4632.2012.05692.x Document Type: Article |
Times cited : (13)
|
References (10)
|